Mass Balance and Absolute Bioavailability Trial of cebranopadol in Healthy Subjects

Trial Profile

Mass Balance and Absolute Bioavailability Trial of cebranopadol in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Jul 2017

At a glance

  • Drugs Cebranopadol (Primary)
  • Indications Back pain; Cancer pain; Diabetic neuropathies; Musculoskeletal pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 03 Jul 2017 New trial record
    • 16 Jun 2017 Results assessing basic PK properties of cebranopadol by means of noncompartmental methods in six phase I clinical trials in healthy subjects published in the Clinical Pharmacokinetics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top